| NCT Number | NCT03223753 |
| Lead Sponsor | Children's Oncology Group
Collaborators: National Cancer Institute (NCI) |
| Conditions | Carcinoma In Situ, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm |
| Enrollment | 299 participants |
| Start Date | 2017-11-29 |
| Primary Completion | 2025-03-31 (estimated) |
| Study Completion | 2026-03-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-24 |